Post-Chemotherapy/Symptom Management Clinical Trials & Research at
Providence Medical Group
Providence Medical Group is currently enrolling patients for the following
post-chemotherapy/symptom management clinical trials:
Study for participants with painful post chemotherapy induced neuropathy
Treatment agent: Single cycle Tetrodotoxin
Physician: Dr Ian Anderson
Study Coordinator: Melissa Ulrich //
melissa.ulrich@providence.org // 707-521-3830
Study Resources:
Study Details | A Randomized, Double-Blind, Placebo Controlled, Multicenter,
Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment
of Chemotherapy Induced Neuropathic Pain | ClinicalTrials.gov
Sponsor: Wex Pharmaceuticals Inc.
Location: Providence Cancer Center Santa Rosa, CA